Results 181 to 190 of about 17,066 (197)

Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease

Annals of Medicine, 2015
Na-Qiong Wu, Yuan-Lin Guo, Jian-Jun Li   +2 more
exaly  

Proprotein Convertase 7

2013
openaire   +1 more source

Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study

Journal of the American Heart Association, 2017
Silvia Marchiano, Sérgio D'Addato, Federica Fogacci   +2 more
exaly  

Proprotein Convertase Subtilisin/Kexin 9 Inhibitors

Journal of Cardiovascular Pharmacology and Therapeutics, 2015
, Simona Dragan, Maria-Corina Şerban
exaly  

Proprotein Convertase 2

2013
openaire   +1 more source

Proprotein Convertase 4

2013
openaire   +1 more source

Proprotein Convertase PCSK9

2013
openaire   +1 more source

Efficiency and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody on Hypercholesterolemia: A Meta‐Analysis of 20 Randomized Controlled Trials

Journal of the American Heart Association, 2015
, Wen Zhang, Chunyu Zeng
exaly  

Proprotein Convertases of Caenorhabditis elegans

2013
A.M. Rose, C. Thacker
openaire   +1 more source

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes

Current Medicinal Chemistry, 2017
Franco Dallegri, Giovanni Camici, Aldo Bonaventura   +2 more
exaly